CMS Halts New Medicare Supplier Enrollment to Combat Fraud
The Trump administration has temporarily halted the enrollment of new suppliers in Medicare for durable medical equipment, aiming to curb fraud within the sector. This six-month moratorium was announced by the Centers for Medicare & Medicaid Services (CMS) and applies to providers of medical supplies like wheelchairs and prosthetics. CMS Administrator Mehmet Oz explained that the pause intends to address a backlog of fraud cases impacting the industry.
This decision aligns with the administration's broader crackdown on healthcare fraud, including forming a task force to address alleged abuses in federal benefits programs. Data from the United States Sentencing Commission indicates a 19.7% rise in healthcare fraud offenses since 2020. A notable case in 2025 saw the Department of Justice indict 15 individuals for over $10.6 billion in fraudulent medical device claims.
Fraud Detection and Prevention
Industry expert Joanne Chiedi, former acting inspector general at the US Department of Health and Human Services, noted that the moratorium could allow CMS and the Office of Inspector General (OIG) to develop better fraud detection systems. She highlighted that past efforts lacked adequate checks and balances necessary for regulatory compliance.
Despite the intended benefits, industry representatives have raised concerns about the moratorium's impact on compliant suppliers. Tom Ryan, president and CEO of the American Association for Homecare, emphasized that this pause could hinder regular business operations for established providers. He highlighted the growing demand for durable medical equipment driven by an aging population and warned against restricting legitimate supplier growth.
Historical Context and Legal Considerations
Historically, CMS has imposed similar enrollment bans in response to fraud concerns, such as the moratorium on home health provider enrollments in Chicago and Miami in 2013. Arielle Lusardi, an attorney with Reed Smith, suggested that a six-month halt might not severely disrupt medical equipment supply chains. However, she warned of potential issues if the ban is prolonged, as hospitals rely on these suppliers for patient discharge needs.
The moratorium specifically targets Medicare enrollment but may influence state Medicaid programs to implement similar measures. CMS's directive hints at possible broader restrictions, prompting increased state-level scrutiny on claims processing and regulatory compliance.
Legal challenges to the moratorium are limited due to the statutory powers granted to CMS under the Social Security Act, which restricts judicial review. Tracy Weir, an attorney at DLA Piper, affirmed that the statute provides CMS clear authority in this matter. Despite these challenges, Ryan indicated that the industry is lobbying for exemptions for experienced providers with a track record of compliance, hoping for constructive dialogue with CMS.